Tribunal reviews research approval and bad debts claim under Income Tax Act

The Tribunal partly allowed the assessee's appeal, directing verification of approval for in-house scientific research under Section 35(2AB) and re-examination of the nature of expenditure. The Tribunal upheld re-examination of bad debts claim under Section 36(1)(vii) and dismissed the Revenue's appeal. Procedural compliance and substantive fulfillment were emphasized for deductions and allowances under the Income Tax Act.

---

---

Issues Involved:
1. Disallowance of weighted deductions under Section 35(2AB) of the Income Tax Act.
2. Nature of expenditure incurred under Section 35(2AB) - Capital or Revenue.
3. Addition on account of bad debts.
4. Deduction under Section 80G.
5. Deduction under Section 80IB.

Detailed Analysis:

1. Disallowance of Weighted Deductions under Section 35(2AB):
The assessee, engaged in the business of manufacturing and marketing pharmaceuticals, claimed a deduction of Rs. 1,05,65,392 for in-house scientific research under Section 35(2AB). The Assessing Officer disallowed the claim, stating the approval must be obtained from the Secretary, DSIR, not from a Scientist-G. The Commissioner (Appeals) upheld this, emphasizing the necessity of approval in the prescribed form. However, the Tribunal recognized that procedural defects should not deny the benefit if the substantive requirements are met. The Tribunal directed the Assessing Officer to verify if the approval was granted by DSIR for the relevant assessment year and to consider the expenditure under Section 35(1) or Section 37 if no approval was available.

2. Nature of Expenditure Incurred under Section 35(2AB) - Capital or Revenue:
The assessee argued that the expenditure of Rs. 70,43,595 on in-house R&D was revenue in nature and should be allowed as a business expense under Section 37. The Commissioner (Appeals) rejected this, stating the expenditure provided long-term benefits and was capital in nature. The Tribunal directed the Assessing Officer to re-examine the nature of the expenditure and allow it under Section 35(1) or Section 37 if it was revenue in nature.

3. Addition on Account of Bad Debts:
The assessee wrote off bad debts amounting to Rs. 1,08,48,954, but the Assessing Officer disallowed the claim, citing a lack of documentary evidence. The Commissioner (Appeals) directed the Assessing Officer to re-examine the claim, referencing the Supreme Court's decision in TRF Ltd. v/s CIT. The Tribunal found that only Rs. 8,24,978 pertained to Auribindo Pharma, with the rest related to different parties. The Tribunal upheld the Commissioner (Appeals)'s direction to re-examine the conditions under Section 36(1)(vii) and allow the amount written off in the books.

4. Deduction under Section 80G:
The Commissioner (Appeals) directed the Assessing Officer to verify the claim for deduction under Section 80G but did not allow it himself. The Tribunal dismissed this ground as the assessee's net income was in loss, making the claim insignificant.

5. Deduction under Section 80IB:
The Commissioner (Appeals) directed the Assessing Officer to verify the claim for deduction under Section 80IB. The Tribunal agreed that if the income assessed is positive after giving effect to the order, the deduction should be allowed.

Conclusion:
The assessee's appeal was partly allowed for statistical purposes, directing further verification and re-examination on several issues. The Revenue's appeal was dismissed, upholding the Commissioner (Appeals)'s directions regarding the bad debts claim. The Tribunal emphasized procedural compliance and substantive fulfillment of conditions for deductions and allowances under the Income Tax Act.

---